Private Advisor Group LLC grew its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 2.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 32,279 shares of the company’s stock after acquiring an additional 834 shares during the period. Private Advisor Group LLC’s holdings in Clorox were worth $5,242,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Brooklyn Investment Group lifted its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter worth about $27,000. Continuum Advisory LLC lifted its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc bought a new position in shares of Clorox during the fourth quarter worth about $32,000. Finally, Catalyst Capital Advisors LLC bought a new position in shares of Clorox during the third quarter worth about $54,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the stock. Barclays increased their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $158.21.
Clorox Stock Performance
CLX opened at $157.41 on Friday. The business’s 50 day moving average is $157.72 and its 200-day moving average is $159.73. The stock has a market cap of $19.39 billion, a PE ratio of 43.01, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm earned $2.16 EPS. On average, analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Manufacturing Stocks Investing
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What Is WallStreetBets and What Stocks Are They Targeting?
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Are Growth Stocks and Investing in Them
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.